GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Modern Chinese Medicine Group Co Ltd (HKSE:01643) » Definitions » Financial Strength

Modern Chinese Medicine Group Co (HKSE:01643) Financial Strength : 10 (As of Dec. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Modern Chinese Medicine Group Co Financial Strength?

Modern Chinese Medicine Group Co has the Financial Strength Rank of 10. It shows strong financial strength and is unlikely to fall into distressed situations.

Good Sign:

Modern Chinese Medicine Group Co Ltd shows strong financial strength.

GuruFocus Financial Strength Rank measures how strong a company's financial situation is. It is based on these factors:

1. The debt burden that the company has as measured by its Interest Coverage (current year). The higher, the better.
2. Debt to revenue ratio. The lower, the better.
3. Altman Z-Score.

Modern Chinese Medicine Group Co's Interest Coverage for the quarter that ended in Dec. 2023 was 29,833.00. Modern Chinese Medicine Group Co's debt to revenue ratio for the quarter that ended in Dec. 2023 was 0.00. As of today, Modern Chinese Medicine Group Co's Altman Z-Score is 4.96.


Competitive Comparison of Modern Chinese Medicine Group Co's Financial Strength

For the Drug Manufacturers - General subindustry, Modern Chinese Medicine Group Co's Financial Strength, along with its competitors' market caps and Financial Strength data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Modern Chinese Medicine Group Co's Financial Strength Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Modern Chinese Medicine Group Co's Financial Strength distribution charts can be found below:

* The bar in red indicates where Modern Chinese Medicine Group Co's Financial Strength falls into.



Modern Chinese Medicine Group Co Financial Strength Calculation

GuruFocus Financial Strength Rank measures how strong a company's financial situation is. It is based on these factors

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

1. The debt burden that the company has as measured by its Interest Coverage (current year). The higher, the better.

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:

Modern Chinese Medicine Group Co's Interest Expense for the months ended in Dec. 2023 was HK$-0.0 Mil. Its Operating Income for the months ended in Dec. 2023 was HK$29.8 Mil. And its Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was HK$0.0 Mil.

Modern Chinese Medicine Group Co's Interest Coverage for the quarter that ended in Dec. 2023 is

Interest Coverage=-1*Operating Income (Q: Dec. 2023 )/Interest Expense (Q: Dec. 2023 )
=-1*29.833/-0.001
=29,833.00

The higher the ratio, the stronger the company's financial strength is.

Good Sign:

Ben Graham prefers companies' interest coverage to be at least 5. Modern Chinese Medicine Group Co Ltd has enough cash to cover all of its debt. Its financial situation is stable.

2. Debt to revenue ratio. The lower, the better.

Modern Chinese Medicine Group Co's Debt to Revenue Ratio for the quarter that ended in Dec. 2023 is

Debt to Revenue Ratio=Total Debt (Q: Dec. 2023 ) / Revenue
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Revenue
=(0.079 + 0) / 358.724
=0.00

3. Altman Z-Score.

Z-Score model is an accurate forecaster of failure up to two years prior to distress. It can be considered the assessment of the distress of industrial corporations.

The zones of discrimination were as such:

When Z-Score is less than 1.81, it is in Distress Zones.
When Z-Score is greater than 2.99, it is in Safe Zones.
When Z-Score is between 1.81 and 2.99, it is in Grey Zones.

Modern Chinese Medicine Group Co has a Z-score of 4.96, indicating it is in Safe Zones. This implies the Z-Score is strong.

Good Sign:

Altman Z-score of 4.96 is strong.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Modern Chinese Medicine Group Co  (HKSE:01643) Financial Strength Explanation

The maximum rank is 10. Companies with rank 7 or higher will be unlikely to fall into distressed situations. Companies with rank of 3 or less are likely in financial distress.

Modern Chinese Medicine Group Co has the Financial Strength Rank of 10. It shows strong financial strength and is unlikely to fall into distressed situations.


Modern Chinese Medicine Group Co Financial Strength Related Terms

Thank you for viewing the detailed overview of Modern Chinese Medicine Group Co's Financial Strength provided by GuruFocus.com. Please click on the following links to see related term pages.


Modern Chinese Medicine Group Co (HKSE:01643) Business Description

Traded in Other Exchanges
N/A
Address
No. 88 Jinwei Road, Hebei, Chengde, CHN, 068150
Modern Chinese Medicine Group Co Ltd is engaged in the production of proprietary Chinese medicine. It offers both OTC and prescribed medicines intended for use by the Middle-aged and the Elderly in the PRC. Its products include Vigour and Vitality Supplement Pill, Circulation Enhancement Pill, Cardiotonic Enhancement Capsule, Kidney Invigoration Pill, Heart Wellness Capsule, Menstrual Discomfort Relief Pill, Liver Detox Tablet, and Additional Ingredient Huoxiang ZhengQi Pill and Fever-removing and Detoxification Pill. The Group has one operating segment of its business as a whole as the production of PCM. Geographically, the majority is from PRC.
Executives
Sun Xinlei 2201 Interest of corporation controlled by you
Xian Dai Sheng Wu Ke Ji Ji Tuan Kong Gu You Xian Gong Si 2101 Beneficial owner
Xie Wei 2201 Interest of corporation controlled by you

Modern Chinese Medicine Group Co (HKSE:01643) Headlines

No Headlines